Total glycosides of Yupingfeng protects against bleomycin-induced pulmonary fibrosis in rats associated with reduced high mobility group box 1 activation and epithelial–mesenchymal transition-Reference-Cited by-同舟云学术

Total glycosides of Yupingfeng protects against bleomycin-induced pulmonary fibrosis in rats associated with reduced high mobility group box 1 activation and epithelial–mesenchymal transition

Published:2015-09-28 Issue:12 Volume:64 Page:953-961
ISSN:1023-3830
Container-title:Inflammation Research
language:en
Short-container-title:Inflamm. Res.

Author:

Cui Wenhui,Li Liucheng,Li Delin,Mo Xiaoting,Zhou Wencheng,Zhang Zhihui,Xu Liang,Zhao Ping,Qi Lianwen,Li Ping,Gao Jian

Funder

The National Natural Science Fundation of China

the Open Project Program of State Key Laboratory of Natural Medicines

Traditional Chinese medicine research project of the health department of Anhui Province

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology,Immunology

Link

http://link.springer.com/content/pdf/10.1007/s00011-015-0878-x.pdf

Reference32 articles.

1. Borensztajn K, Crestani B, Kolb M. Idiopathic pulmonary fibrosis: from epithelial injury to biomarkers—insights from the bench side. Respiration. 2013;86:441–52.

2. Wynn TA, Ramalingam TR. Mechanisms of fibrosis: therapeutic translation for fibrotic disease. Nat Med. 2012;18:1028–40.

3. Pankov R, Yamada KM. Fibronectin at a glance. J Cell Sci. 2002;115:3861–3.

4. Chen YL, Zhang X, Bai J, Gai L, Ye XL, Zhang L, et al. Sorafenib ameliorates bleomycin-induced pulmonary fibrosis: potential roles in the inhibition of epithelial–mesenchymal transition and fibroblast activation. Cell Death Dis. 2013;4:e665.

5. Zhao H, Wu QQ, Cao LF, Qing HY, Zhang C, Chen YH, et al. Melatonin inhibits endoplasmic reticulum stress and epithelial–mesenchymal transition during bleomycin-induced pulmonary fibrosis in mice. PLoS One. 2014;9:e97266.

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. HMGB1 as an extracellular pro-inflammatory cytokine: Implications for drug-induced organic damage;Cell Biology and Toxicology;2024-07-15

2. Chinese medicine as a therapeutic option for pulmonary fibrosis: Clinical efficacies and underlying mechanisms;Journal of Ethnopharmacology;2024-01

3. HMGB1 inhibition reduces TDI-induced occupational asthma through ROS/AMPK/autophagy pathway;Ecotoxicology and Environmental Safety;2023-11

4. Pachymic Acid Protects Against Bleomycin-Induced Pulmonary Fibrosis by Suppressing Fibrotic, Inflammatory, and Oxidative Stress Pathways in Mice;Applied Biochemistry and Biotechnology;2023-08-31

5. Advances in the chemical constituents, pharmacological properties and clinical applications of TCM formula Yupingfeng San;Fitoterapia;2023-01